Lantheus Holdings Inc (LNTH)
- Exchange
- NASDAQ
- Symbol
- LNTH
- Sector
- Life Sciences
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Description
- Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
- Country
- USA
Stock price
At close: November 5, 2024
-
Open112.85
-
High115.09
-
Low110.17
-
Close114.96
-
Volume1,490,730
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
16.14
Receivables turnover
4.49
Payables turnover
25.09
Working capital turnover
1.42
Days of inventory on hand (DOH)
22.61
Days of sales outstanding (DSO)
81.30
Number of days of payables
14.55
Fixed asset turnover
8.70
Total asset turnover
0.77
Current ratio
5.80
Quick ratio
5.33
Cash ratio
3.81
Cash conversion cycle
89.36
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.02
Interest coverage
21.53
Gross profit margin
55.59%
Operating profit margin
28.57%
Pretax margin
32.20%
Net profit margin
25.59%
Operating return on assets (Operating ROA)
22.08%
Return on assets (ROA)
19.78%
Return on total capital
52.82%
Return on equity (ROE)
40.04%